Amesergide
Alternative Names: LY 237733Latest Information Update: 22 Jul 2011
At a glance
- Originator Eli Lilly and Company
- Class Ergolines; Small molecules
- Mechanism of Action Serotonin 1C receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders; Erectile dysfunction; Major depressive disorder; Migraine; Premature ejaculation; Schizophrenia; Thrombosis
Most Recent Events
- 22 Jul 2011 Discontinued - Phase-II for Erectile dysfunction in USA (PO)
- 22 Jul 2011 Discontinued - Phase-II for Premature ejaculation in USA (PO)
- 22 Jul 2011 Discontinued - Preclinical for Major depressive disorder in USA (PO)